FY2024 EPS Forecast for PTC Therapeutics Boosted by Analyst
Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for PTC Therapeutics in a report ...
Gabrielle White appointed president of Irish Exporters Association
Gabrielle White has been appointed as president of the Irish Exporters Association, the organisation said on Thursday. She ...
PTC Therapeutics: Navigating Revenue Challenges and Uncertain Outlook Amidst DMD Franchise Erosion
Leerink Partners analyst Joseph Schwartz has maintained their neutral stance on PTCT stock, giving a Hold rating yesterday.Stay Ahead of the ...
Finanznachrichten4d
PTC Therapeutics, Inc.: PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 3, 2025, the company approved 1,200 restricted stock units ("RSUs"), each representing ...
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 3, 2025, the company approved 1,200 restricted stock units ("RSUs"), each representing the right to receive one share of its common ...
PTC Therapeutics Surpasses Expectations with Strong 2024 Financials and Promising 2025 Outlook
Analyst Jeffrey Hung of Morgan Stanley maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), retaining the price target of ...
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at ...